Copyright
©The Author(s) 2019.
World J Gastrointest Pharmacol Ther. Jan 21, 2019; 10(1): 22-28
Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.22
Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.22
Table 1 Patient characteristics n (%)
| FGID patients (n = 39) | Non-FGID patients (n = 458) | Total (n = 497) | |
| Mean age (yr) | 51.2 | 53.0 | 52.9 |
| Sex (Female) | 29 (74.4) | 220 (48.0) | 249 (50.1) |
| Disability/Medicaid status | 4 (10.3) | 14 (3.1) | 18 (3.6) |
| Tobacco use | 7 (17.9) | 36 (7.9) | 43 (8.7) |
| Alcohol use | 12 (30.8) | 185 (40.4) | 197 (39.6) |
| History of depression | 9 (23.1) | 59 (12.9) | 68 (13.7) |
| History of anxiety | 9 (23.1) | 13 (2.8) | 22 (4.4) |
| Disease extent | |||
| Proctitis | 6 (15.4) | 39 (8.5) | 45 (9.1) |
| Left sided | 12(30.8) | 153 (33.4) | 165 (33.2) |
| Extensive | 20 (51.3) | 227 (49.6) | 247 (49.7) |
| Average disease duration (yr) | 8.2 | 7.5 | 7.6 |
- Citation: Chitnavis MV, Baray M, Northup PG, Tuskey AG, Behm BW. Opioid use and misuse in ulcerative colitis. World J Gastrointest Pharmacol Ther 2019; 10(1): 22-28
- URL: https://www.wjgnet.com/2150-5349/full/v10/i1/22.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v10.i1.22